Takeda Sues India's Wockhardt For Applying For Actos Generic In U.S.
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals and its U.S. subsidiary have sued Wockhardt and its U.S. units for violating patents on Takeda's Actos (pioglitazone) diabetes drug